Here, we were able to more precisely perform late stage survival predictions by using only the two-gene signature of the M1 (IL-1β) and M2 (TGF-β1) genes directly from MPE-Mφ or lung cancer tissues. This evidence concerns the gene IL1B and lung cancer.